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Purpose. To evaluate the diagnostic accuracy of retinal ganglion cell (RGC) counts as estimated by combining data from standard
automated perimetry (SAP) and spectral domain optical coherence tomography (SD-OCT). Methods. Healthy individuals and
glaucoma patients were included in this cross-sectional study. All eyes underwent 24-2 SITA SAP and structural imaging tests.
RGC count estimates were obtained using a previously described algorithm, which combines estimates of RGC numbers from
SAP sensitivity thresholds and SD-OCT retinal nerve fiber layer (RNFL) average thickness. Results. A total of 119 eyes were
evaluated, including 75 eyes of 48 healthy individuals and 44 eyes of 29 glaucoma patients. RGC count estimates performed
better than data derived from SD-OCT RNFL average thickness or SAP mean deviation alone (area under ROC curves: 0.98,
0.92, and 0.79; P < 0 001) for discriminating healthy from glaucomatous eyes, even in a subgroup of eyes with mild disease
(0.97, 0.88, and 0.75; P < 0 001). There was a strong and significant correlation between estimates of RGC numbers derived from
SAP and SD-OCT (R2 = 0 74; P < 0 001). Conclusion. RGC count estimates obtained by combined structural and functional data
showed excellent diagnostic accuracy for discriminating the healthy from the glaucomatous eyes and performed better than
isolated structural and functional parameters.
1. Introduction
Glaucoma is a neuropathy characterized by retinal ganglion
cell (RGC) degeneration resulting in progressive neuroretinal
rim thinning and severe excavation of the optic nerve head
[1, 2]. These structural changes are often followed by
functional losses that may affect vision-related quality of life
[3]. Glaucoma can remain asymptomatic until the disease
reaches an advanced stage [4].
The definitive diagnosis of glaucoma is based on struc-
tural changes in the optic nerve head consistent with visual
field loss. However, in early stages, patients may present with
structural defects in either the optic nerve head or the retinal
nerve fiber layer (RNFL) that precede any visual field changes
detected by standard automated perimetry (SAP) [5, 6]. On
the other hand, many patients in advanced stages of
glaucoma show evidence of functional deterioration, but
without measurable changes in currently available structural
tests [7, 8]. Therefore, the combined use of structural and
functional tests would be expected to lead to an earlier
diagnosis of glaucoma and a better likelihood of detection
of its progression in advanced stages [9, 10].
Neither SAP nor optical coherence tomography (OCT) is
able to detect RGC loss directly. Based on experimental
studies in monkeys, Harwerth et al. [11] derived an empirical
model relating sensitivity measurements in SAP to histologi-
cal RGC density as a function of retinal eccentricity. The
experimental model was then translated to clinical perimetry
in humans and allowed the estimation of RGC numbers from
SAP sensitivity thresholds [12]. Other formulas including the
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RNFL thickness measured by OCT were developed to also
estimate the number of RGCs [13]. Harwerth et al. [11]
demonstrated that RGC losses estimated by clinical perime-
try were in close agreement with those estimated by OCT.
Appropriate measurement scales for sensitivity, retinal
eccentricity, and age-related neural losses were considered
the key parameters for estimation of RGC losses [11].
Based on those empirical formulas, Medeiros et al.
[14, 15] developed an algorithm to estimate RGC counts,
which combines estimates of RGC counts from both SAP
sensitivity thresholds and OCT average RNFL thickness
measurements. The method includes a weighting system
that provides greater emphasis to RGC estimates from
OCT in early glaucoma and greater emphasis to estimates
from SAP in advanced disease [13–15]. RGC count estimates
derived from functional and structural tests have been shown
to perform significantly better than isolated structural and
functional parameters for diagnosing, staging, and monitor-
ing the progression of glaucomatous damage [14–17].
The purpose of this study was to evaluate the glaucoma
diagnostic accuracy of RGC counts as estimated by com-
bining data from SAP sensitivity thresholds and average
RNFL thickness measured by OCT. We also established a
correlation between RGC estimates obtained from SAP and
OCT data.
2. Materials and Methods
This observational, cross-sectional study was approved by
the Ethical Committee of the Federal University of São Paulo
and was performed in accordance with the ethical standards
laid down in the Declaration of Helsinki and the Interna-
tional Conference on Harmonisation Guidelines for Good
Clinical Practice [18]. Informed consent was obtained from
all individual participants included in the study.
All subjects underwent a comprehensive ophthalmologic
examination by a glaucoma specialist including review of
medical history, best-corrected visual acuity, slit-lamp biomi-
croscopy, Goldmann applanation tonometry, gonioscopy,
and dilated fundoscopic examination. Only subjects older
than 40 years with open angles on gonioscopy were included.
Subjects were excluded if they presented with a best-
corrected visual acuity of less than 20/40 in healthy subjects
or 20/80 in glaucoma patients, spherical refraction outside
±5.0 diopters and/or cylinder correction outside 3.0 diopters,
or any other ocular or systemic disease that could affect the
optic nerve, RNFL, or the visual field. Patients with ocular
media opacities that interfered with the exams or subjects
on whom cataract surgery was performed at least six months
prior to the first attempt were also excluded.
Healthy subjects were recruited from the general popula-
tion and were required to have a normal ophthalmologic
examination, intraocular pressure below 22mmHg, absence
of optic neuropathy, and normal visual field tests in both
eyes. Eyes were classified as glaucomatous if glaucomatous
optic neuropathy was evident in masked grading of optic disc
stereophotographs and repeatable abnormal visual field test
results. All subjects that presented only one of the previous
criteria were excluded from the sample.
Glaucoma patients were recruited from the Glaucoma
and General Clinic at the Ophthalmology Department of
the Federal University of São Paulo, Brazil. Healthy subjects
were recruited from the general clinic or hospital staff.
2.1. Optic Disc and Posterior Pole Evaluation. Stereophoto-
graphs were obtained with the Visucam® Pro NM (Carl
Zeiss Meditec, Dublin, CA, USA). Two glaucoma specialists
blinded to the clinical diagnosis reviewed digital stereoscopic
images with a stereoscopic viewer. In case of disagreement, a
third observer served as an adjudicator. Glaucomatous optic
neuropathy was defined by the presence of neuroretinal rim
thinning (localized or diffused) or peripapillary RNFL defects
(localized or diffused). RNFL slit defects narrower than the
diameter of adjacent vessels were not included.
2.2. Visual Field Testing. All patients underwent SAP testing
using Humphrey field analyzer (HFA-II®; Carl Zeiss Medi-
tec, Dublin, CA, USA) and Swedish interactive thresholding
algorithm standard 24-2 test less than six months apart from
imaging. If a subject presented a visual field with more than
33% false-negative errors, 15% false-positive errors, or more
than 20% fixation losses, this exam was excluded and the
subject was rechecked. Normal visual fields were defined
based on mean deviation (MD) and pattern standard devia-
tion (PSD) within 95% confidence limits and a glaucoma
hemifield test (GHT) within normal limits. An abnormal
SAP test was defined as a visual field with PSD outside the
95% confidence limits or a GHT outside normal limits or a
cluster of three points with a probability of less than 5% on
a pattern deviation map at least one point with a probability
of less than 1% in two consecutive reliable visual fields.
2.3. Optical Coherence Tomography. Subjects underwent
ocular imaging with dilated pupils using an optical coherence
tomograph, the Spectralis™ OCT (software version 5.1.3;
Heidelberg Engineering, Dossenheim, Germany). The exam-
iner was required to manually center the scan on the optic
disc. To increase the image quality, the device included an
automatic real-time function that gathered multiple frames,
and images were averaged to reduce noise.
As previously described, infrared reflection images
(λ=820nm) and OCT B-scans (λ=870 nm, 40,000 A-
scans/s) of the dual-laser scanning systems of the Spectralis
OCT were acquired simultaneously; 3.4mm-wide circular
scans were taken (768 A-scans) around the optic disc. The
average peripapillary RNFL thickness was automatically
calculated by the software using a circular scan pattern with
12 degrees (3.5 to 3.6mm) in diameter. Only exams with a
signal strength of more than 15 (as suggested by the
manufacturer), clear fundus image visualization, and a scan
pattern without any artifacts or other algorithm failure were
included in the analyses [19, 20].
2.4. Estimation of Retinal Ganglion Cell Number. The
estimate of RGC count was based on previous works on the
development and validation of a model linking structure
and function in glaucoma [11, 12, 14, 15, 21, 22]. The model
combines SAP and OCT measurements to provide a final
estimate of RGC count in each eye.
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Briefly, the first part of the algorithm obtained a SAP-
derived estimate of the total number of RGCs (SAPrgc) by
adding the estimates from all locations in the visual field, thus
relating sensitivity measurements in SAP to histological RGC
counts as a function of retinal eccentricity. The structural
part of the model consisted in estimating the number
of RGC axons from RNFL thickness measured by OCT
(OCTrgc), considering the effect of age in RNFL, as
detailed elsewhere [15, 16].
A combined measure was calculated by averaging the
estimates of RGC numbers obtained from SAP and from
OCT, weighted according to the severity of the disease. The
following equation was used:
Estimated RGC count = 1 + MD30 × OCTrgc
+ −MD30 × SAPrgc
1
2.5. Statistical Analyses. All statistical analyses were per-
formed with Stata software (Stata version 13; StataCorp,
College Station, TX, USA). Welch’s t-test was used to
compare age, SAP MD, SAP PSD, and average RNFL thick-
ness of unequal samples. The area under receiver operating
characteristic (AROC) curves was used to compare the
diagnostic accuracy of average RNFL thickness, SAP MD,
and the estimated RGC count [23]. Data were adjusted for
age and intereye dependency effect with bootstrapping with
10,000 replications [24]. The alpha level (type I error) was
set at 0.05.
3. Results
A total of 119 eyes (77 participants) were evaluated, including
75 eyes of 48 healthy subjects and 44 eyes of 29 glaucoma
patients. The mean age was significantly higher in glaucoma
patients than in controls (68.1± 11.3 years versus 58.6± 8.8
years; P < 0 001). Average SAP MD was significantly lower
in glaucoma patients than healthy subjects (−7.91± 6.81 dB
versus −1.05± 1.05 dB; P < 0 001). The glaucomatous eyes
had a wide range of disease severity, with SAP MD values
ranging from −0.71 dB to −30.15 dB and SAP PSD rang-
ing from 1.65 dB to 15.26 dB. Average RNFL thickness
was significantly lower in glaucoma patients than in con-
trols (73.54± 16.54μm versus 100.07± 10.01μm; P < 0 001)
(Table 1). Healthy subjects demonstrated a significantly
higher mean estimated number of RGCs than did the
glaucoma group (986,396± 143,315 cells versus 535,479±
204,646 cells; P < 0 001).
The diagnostic performance of estimated RGC count was
significantly better than that of RNFL thickness measured by
OCT or SAP MD for discriminating the glaucomatous eyes
from the healthy eyes, with AROCs of 0.98, 0.92, and 0.79
(P < 0 001) (Figure 1(a)). Moreover, the estimated RGC
count also presented significantly higher AROC than RNFL
thickness measured by OCT or SAP MD in the eyes with
MD≥−6 dB (0.97, 0.88, and 0.75; P < 0 001) (Figure 1(b)).
Pairwise comparisons were performed on estimated RGC
counts, RNFL thickness, and SAP MD and were determined
to be statistically significant (Table 2).
However, when data were adjusted for age and intereye
dependency, the difference between estimated RGC count,
RNFL thickness, and SAP MD showed borderline statistical
significance (AROCs of 0.95, 0.88, and 0.68, resp.; P = 0 05).
There was no statistically significant difference between the
groups in pair comparison after adjusting for age and binoc-
ularity. The diagnostic performance of estimated RGC count,
RNFL thickness, and SAP MD was significantly different in
the eyes with SAP MD≥−6 dB (0.92, 0.82, and 0.60, resp.;
P = 0 04). Moreover, there were no significant differences in
pair comparison between the three parameters (Table 2).
4. Discussion
In the present study, RGC count estimates based on an algo-
rithm that combines structural and functional parameters
had a better accuracy for discriminating glaucomatous from
the healthy eyes than isolated SAP or OCT measurements.
The estimated RGC count in the glaucomatous eyes was
lower than that in healthy subjects (535,439± 204,646 cells
versus 986,396± 143,315 cells). In a cohort of patients with
glaucoma in the early stage of development of visual field
defects (MD=−2.17± 1.34), Medeiros et al. [16] observed
an estimated RGC count of 652,057± 115,829 in the glauco-
matous eyes and 910,584± 142,412 cells in normal subjects.
The diagnostic accuracy of the estimated RGC count
was significantly better than the isolated average RNFL
thickness of Spectralis OCT and SAP MD (AROCs of
0.98, 0.92, and 0.79). These results corroborate the previ-
ous study of Medeiros et al. [14], who observed that the
Table 1: Demographic and clinical characteristics of the study participants (n = 119).
Healthy subjects (n = 75) Glaucoma patients (n = 44)
Mean± SD Range Mean± SD Range
Age (years) 58.6± 8.8 44.6 to 77.9 68.1± 11.3∗ 44.7 to 85.6
SAP MD (dB) −1.05± 1.05 −3.57 to 1.42 −7.91± 6.81∗ −30.15 to −0.71
SAP PSD (dB) 1.52± 0.22 1.10 to 1.98 6.56± 4.55∗ 1.65 to 15.26
RNFL thickness (μm) 100.07± 10.01 80 to 128 73.54± 16.54∗ 39 to 107
Estimated RGC count 986,396± 143,315 722,128 to 1,381,549 535,479± 204,646∗ 34,128 to 889,775
SAP MD: standard automated perimetry mean deviation; SAP PSD: standard automated perimetry pattern standard deviation; RNFL: retinal nerve fiber layer;
RGC: retinal ganglion cell. ∗P < 0 001, healthy subjects versus glaucoma patients. Welch’s t-test was used to compare age, SAP MD, SAP PSD, and average
RNFL thickness of unequal samples.
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accuracy of the estimated RGC count was higher than
Cirrus™ OCT average RNFL thickness and SAP MD
(AROCs of 0.95, 0.92, and 0.88). Another study also
showed an accuracy of the estimated RGC count better
than the Cirrus OCT RNFL thickness (AROCs 0.95
and 0.88) [16].
The estimated RGC count also presented a better perfor-
mance to differentiate the healthy and glaucomatous eyes
in a subgroup of patients with MD≥−6 dB in comparison
with RNFL thickness and SAP MD (AROCs of 0.97, 0.88,
and 0.75). Sihota et al. [25] observed similar AROC of
RNFL thickness to separate the normal from the early
glaucomatous eyes (0.90) in a protocol using Stratus™
OCT. However, the AROC was lower when this parameter
was used to differentiate the early and moderate glaucoma-
tous eyes (0.70). In a study with healthy and preperimetric
eyes, Medeiros et al. [14] observed similar accuracy for RNFL
thickness (0.88), but lower for SAP MD (0.63). In our study,
we did not observe a considerable decrease in the AROC of
the estimated RGC count when it was tested in patients with
early-stage glaucoma.
In the present study, there was a significant difference
in age between the glaucoma and the control groups;
furthermore, some subjects had both eyes included in
the sample. To minimize the effect of these variables in
the analyses, a covariate adjustment was used in the
AROC evaluation [26]. After the corrections, the esti-
mated RGC count was significantly more accurate than
both RNFL thickness and SAP MD with all patients
included (AROCs of 0.95, 0.88, and 0.68; P = 0 05);
similar results were obtained in the eyes with SAP
MD≥−6 dB (0.92, 0.82, and 0.60; P = 0 04). However,
the differences between AROCs of these three parameters
showed borderline or not significant statistical difference.
Even though our results are in accordance with the
literature, with regard to accuracies and differences
among them, the limitation that both the mean lower
age of the control group and the sample size made those
differences not significant. Therefore, our results ratify
the value of the estimated RGC count as an important
parameter to the correlation of structure and function tests
in glaucoma evaluation.
Table 2: Differences between unadjusted data and data adjusted for
age and binocularity.
P value
Unadjusted
data
Adjusted
dataa
All eyes
Estimated RGC count versus RNFL
versus SAP MD
<0.001 0.05
Estimated RGC count versus RNFL 0.004 0.06
Estimated RGC count versus SAP MD <0.001 0.08
RNFL versus SAP MD 0.007 0.19
MD≥−6 dB
Estimated RGC count versus RNFL
versus SAP MD
<0.001 0.04
Estimated RGC count versus RNFL 0.005 0.08
Estimated RGC count versus SAP MD <0.001 0.06
RNFL versus SAP MD 0.03 0.19
SAP MD: standard automated perimetry mean deviation; RNFL: retinal
nerve fiber layer thickness (average value); RGC: retinal ganglion cell.
aAdjusted for age and binocularity.
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Figure 1: Receiver operating characteristic (ROC) curves for discriminating between the healthy and glaucomatous eyes. (a) The area under
ROC curves was 0.98, 0.92, and 0.79 for estimated retinal ganglion cell (RGC) count, average retinal nerve fiber layer (RNFL) thickness, and
standard automated perimetry mean deviation (SAPMD), respectively. (b)When eyes withMD<−6 dB were excluded, estimated RGC count
also showed better diagnostic performance (area under ROC curves of 0.97, 0.88, and 0.75; P < 0 001). Black line: estimated RGC count;
dashed line: average RNFL thickness; dotted line: SAP MD.
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There are other methods to estimate the number of RGCs
in the human retina. Recently, Raza and Hood [27] devel-
oped one such method in which the RGC density was
obtained from the literature and the thickness of macular
RGC layer was measured directly with a swept-source (SS)
OCT [28]. The mean estimated RGC number presented a
good agreement with estimates of visual sensitivity and histo-
logical counts. Moreover, the studied parameter showed a
lower variance when compared to the RGC count obtained
with Harwerth’s algorithm [11]. Unfortunately, we could
not include it in our study because we did not have an SS-
OCT available at the time of the study, and the Spectralis
OCT software used in this study did not have macular or
optic disc analyses.
There were some limitations in the present study. Empir-
ically derived formulas to estimate the number of RGCs from
SAP and OCT data and the estimates of RGC count were not
based on direct histologic RGC counts in humans. However,
the formulas have been validated on histological studies in
monkeys and applied to multiple external cohorts in humans
[11, 16] Other limitations were a small sample size, a limited
number of eyes in different stages of glaucoma, the use of
multiple comparisons, and the age difference between the
healthy and glaucoma groups. Moreover, the definition of
glaucoma through the structural evaluation of the optical disc
and RNFL defects could overestimate the diagnostic accuracy
of the structural measure (average RNFL thickness) OCT
regarding the accuracy of the functional measure from SAP.
There was a significant strong correlation between RGC
estimates obtained from SAP and Spectralis OCT data. The
estimated count of RGCs obtained by combining the RNFL
thickness of Spectralis OCT with SAP sensitivity showed
excellent diagnostic accuracy for discriminating between
the normal and glaucomatous eyes, even in earlier stages of
the disease. This accuracy was better than the structural
and functional parameters isolated; however, after adjusting
for age and dependency between the eyes, the differences
between these parameters showed borderline or no statistical
significance. Furthermore, when analyzing the early-stage
glaucoma subgroup, the differences between the accuracies
were statistically significant.
Finally, the present study corroborates previous pub-
lished results but using a different OCT device (Spectralis
OCT); moreover, it replicates the use of the estimated RGC
count algorithm in an independent study population with a
different racial composition. The purposed algorithm is an
important diagnostic tool that mixes structural and func-
tional parameters for glaucoma diagnosis and that also seems
to have a great potential to be used for follow-up.
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